We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,033 results
  1. Hotspots and trends of microglia in Alzheimer's disease: a bibliometric analysis during 2000–2022

    Background

    Alzheimer's disease is one common type of dementia. Numerous studies have suggested a correlation between Alzheimer's disease and...

    Lijie Zhang, Qiuru Yao, ... Qing Zeng in European Journal of Medical Research
    Article Open access 24 January 2024
  2. Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis

    Background

    The management of Alzheimer's disease (AD) poses considerable challenges, necessitating the pursuit of innovative therapeutic approaches....

    Moaz Elsayed Abouelmagd, Maickel Abdelmeseh, ... Abdallah Abbas in Neurological Sciences
    Article Open access 25 May 2024
  3. Contribution of Iranian researchers in Alzheimer's disease research: A 10 years scientometric analysis

    Background

    Alzheimer's disease is the most common form of dementia and is a rising issue for global health. Iran is struggling with a growing number...

    Arash Ghazbani, Mohammad Javad Mansourzadeh, ... Afshin Ostovar in Journal of Diabetes & Metabolic Disorders
    Article 04 November 2021
  4. Diagnostic performance of MRI radiomics for classification of Alzheimer's disease, mild cognitive impairment, and normal subjects: a systematic review and meta-analysis

    Background

    Alzheimer's disease (AD) is a debilitating neurodegenerative disease. Early diagnosis of AD and its precursor, mild cognitive impairment...

    Ramin Shahidi, Mansoureh Baradaran, ... Houman Sotoudeh in Aging Clinical and Experimental Research
    Article 06 October 2023
  5. Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy

    Introduction

    Alzheimer’s disease is a neurocognitive disorder that affects elderly people by slowly impaired cognition, dementia, and gets worse with...

    Devika Jadhav, Nikita Saraswat, ... Devendra Shirode in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 11 January 2024
  6. Two decades of research on the role of diet in Alzheimer’s disease (2003–2023): a bibliometric and visual analysis based on CiteSpace

    Background

    In recent years, the impact of diet on Alzheimer's disease (AD) as a modifiable lifestyle has attracted widespread attention. We aimed to...

    Wanyin Xu, Zhengyanran Xu, ... **g Wu in Journal of Health, Population and Nutrition
    Article Open access 17 January 2024
  7. Alzheimer’s disease and drug delivery across the blood–brain barrier: approaches and challenges

    Alzheimer's disease (AD) is a diverse disease with a complex pathophysiology. The presence of extracellular β-amyloid deposition as neuritic plaques...

    Iram Iqbal, Fatima Saqib, ... Mohammad S. Mubarak in European Journal of Medical Research
    Article Open access 08 June 2024
  8. Potential role of recombinant growth differentiation factor 11 in Alzheimer’s disease treatment

    Alzheimer's disease (AD) is a neurodegenerative disease closely related to the accumulation of beta-amyloid (Aβ) plaques. Growth differentiation...

    Bryan Gervais de Liyis, Wilson Halim, I. Putu Eka Widyadharma in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 12 May 2022
  9. A comparative study of bibliometric analysis on old adults’ cognitive impairment based on Web of Science and CNKI via CiteSpace

    Introduction

    The purpose of this study was to analyze the current status, the research hot spots and frontiers of cognitive impairment (CI) on old...

    Shuyi Yan, Mingli Pang, ... Fanlei Kong in Health Economics Review
    Article Open access 02 December 2023
  10. PSEN2 and ABCA7 variants causing early-onset preclinical pathological changes in Alzheimer's disease: a case report and literature review

    Background

    Alzheimer’s disease (AD) is a debilitating and highly heritable neurodegenerative disease. Early-onset AD (EOAD) was defined as AD...

    Jiale Gan, Hui Zhou, ... Liangjuan Fang in Neurological Sciences
    Article 26 January 2023
  11. Anti-Alzheimer potential of Solanum lycopersicum seeds: in vitro, in vivo, metabolomic, and computational investigations

    Background

    Solanum lycopersicum Linn. (Tomato, Family Solanaceae) is one of the fruits that are most consumed worldwide. The current research intends...

    Hussain T. Bakhsh, Omnia Hesham Abdelhafez, ... Fatma Alzahraa Mokhtar in Beni-Suef University Journal of Basic and Applied Sciences
    Article Open access 02 January 2024
  12. Low vitamin D serum levels as risk factor of Alzheimer’s disease: a systematic review and meta-analysis

    Past literatures have reported that changes in serum vitamin D levels are related to cognitive dysfunctions, such as dementia, including Alzheimer’s...

    Rizaldy Taslim Pinzon, Theressia Handayani, ... Ranbebasa Bijak Buana in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 03 July 2023
  13. Association between Mediterranean diet and dementia and Alzheimer disease: a systematic review with meta-analysis

    Background

    Dementia affects 5–8% of the population aged over 65 years (~50 million worldwide). Several factors are associated with increased risk,...

    Daniele Nucci, Andrea Sommariva, ... Vincenza Gianfredi in Aging Clinical and Experimental Research
    Article Open access 22 March 2024
  14. Therapeutic Mechanism of Kai **n San on Alzheimer’s Disease Based on Network Pharmacology and Experimental Validation

    Objective

    To explore the specific pharmacological molecular mechanisms of Kai **n San (KXS) on treating Alzheimer’s disease (AD) based on network...

    Kan Wang, Rong Yang, ... Ming-wang Kong in Chinese Journal of Integrative Medicine
    Article 07 December 2022
  15. Markers for the detection of Lewy body disease versus Alzheimer’s disease in mild cognitive impairment: a systematic review and meta-analysis

    Background

    Mild cognitive impairment (MCI) may evolve into dementia. Early recognition of possible evolution to Alzheimer's disease (AD) and dementia...

    Marianna Ilarj Burgio, Nicola Veronese, ... Mario Barbagallo in Aging Clinical and Experimental Research
    Article Open access 07 March 2024
  16. Evaluation of the effects of curcumin on chronic obstructive pulmonary disease with a bio-computational approach

    Background

    According to the increasing trend of COPD, the timely diagnosis and treatment of the disease can reduce the high costs to the health...

    Mohammad Maboudian, Elham Amjad, ... Yousef Javadzadeh in Egyptian Journal of Medical Human Genetics
    Article Open access 29 January 2024
  17. A Systematic Review of Clinical Practice Guidelines for Alzheimer’s Disease and Strategies for Future Advancements

    Introduction

    Alzheimer’s disease (AD) is a disease continuum from pathophysiologic, biomarker and clinical perspectives. With the advent of advanced...

    Amir Abbas Tahami Monfared, N. T. Nhan Phan, ... Harald Hampel in Neurology and Therapy
    Article Open access 01 June 2023
  18. Mechanisms of Acupuncture in Improving Alzheimer’s Disease Caused by Mitochondrial Damage

    Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases among the elderly and it accounts for nearly 80% of all dementias. The...

    Yu-hang Jiang, Jia-kai He, ... Bao-hui Jia in Chinese Journal of Integrative Medicine
    Article 01 March 2022
  19. Akt signaling pathway: a potential therapy for Alzheimer’s disease through glycogen synthase kinase 3 beta inhibition

    Alzheimer’s disease (AD) is a form of dementia marked by the accumulation of neuritic plaques and neurofibrillary tangles through the action of...

    Joshua Limantoro, Bryan Gervais de Liyis, Jane Carissa Sutedja in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 07 November 2023
  20. The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials

    Background

    Alzheimer’s disease (AD) is a worldwide public health problem and is difficult to cure. Drugs aimed at slowing the progression of the...

    Wenxue Wu, Yi Ji, ... Zhong Wang in European Journal of Medical Research
    Article Open access 28 November 2023
Did you find what you were looking for? Share feedback.